Janssen acquires BeneVir Biopharm to advance immunotherapy regimens

3rd May 2018 Uncategorised 0

BeneVir engineers oncolytic viruses tailored to infect and destroy cancer cells

More: Janssen acquires BeneVir Biopharm to advance immunotherapy regimens
Source: News